Baxter R & D Europe FDA Record

Summary

Related names

Each name below has its own page. Its counts cover only the records FDA filed under that name and are not part of the totals for Baxter R & D Europe above.

Recent FDA inspections

2 inspections from Jun 21, 2013 to Feb 2, 2023.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Baxter R & D Europe and the FDA: common questions

Has Baxter R & D Europe received an FDA warning letter?

No FDA warning letter addressed to the name "Baxter R & D Europe" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Baxter R & D Europe received an FDA Form 483?

FDA has not published a Form 483 for "Baxter R & D Europe" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Baxter R & D Europe?

The most recent FDA inspection on file ended Feb 2, 2023 at Braine-L'Alleud, Belgium and was classified VAI. FDA has 2 inspections of Baxter R & D Europe on file.